UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 3, 2024

 

ASP Isotopes Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

001-41555

 

87-2618235

(State or other jurisdiction of

incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

601 Pennsylvania Avenue NW,

South Building, Suite 900

WashingtonDC

 

20004

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (202756-2245

 

 Not Applicable

(Former name or former address, if changed since last report.)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Ticker symbol(s)

 

Name of each exchange on which registered

Common Stock, par value $0.01

 

ASPI

 

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act  

 

 

 

Item 8.01. Other Events.

 

On September 3, 2024, ASP Isotopes Inc. (the “Company”) issued a press release related announcing the completion of the construction phase of the Company’s first quantum enrichment plant for Ytterbium-176 and the hiring of its Global Leader of U.K. Nuclear Strategy.  A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1 and is incorporated herein by reference, other than the fifth, seventh and eighth paragraphs of the press release.

 

Item 9.01. Financial Statements and Exhibits.

 

Exhibit No.

 

Description

99.1

 

Press Release, dated September 3, 2024, of ASP Isotopes Inc. announcing the completion of the construction phase of the Company’s first quantum enrichment plant for Ytterbium-176 and the hiring of its Global Leader of U.K. Nuclear Strategy.

104

 

Cover Page Interactive Date File (embedded within the Inline XBRL document)

 

 
2

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ASP ISOTOPES INC.

 

 

 

 

Date: September 3, 2024

By:

/s/ Paul Mann

 

 

Name:

Paul Mann

 

 

Title:

Chief Executive Officer

 

 

 
3